Trial Reveals Benefits of ‘Stepped’ Palliative Care for Patients with Advanced Lung Cancer
Findings suggest that this is an effective and more scalable means to deliver palliative care to improve patients’ quality of life.
Contact Information
Yawkey, Suite 10B
55 Fruit Street
Boston,
MA
02114
Email: MGHCORE@partners.org
Volunteer/Collaboration Opportunities
If you would like to contact the CORE program to inquire about volunteer or collaboration opportunities, please contact us here.
Support CORE
A gift may be made to the Mass General Cancer Center in support of the Cancer Outcomes Research and Education Program (CORE). Gifts can be made online or mailed to the MGH Development Office, attention: Meagan Coons, 125 Nashua Street, Suite 540, Boston, MA 02114. Checks should be made payable to MGH Cancer Center. Please reference fund 222448. Make a gift.
The Cancer Outcomes Research and Education Program (CORE) is a unique, collaborative research team with members from oncology, nursing, palliative care, psychiatry, and psychology. CORE's breadth of experience as investigators and clinicians enables the team to integrate multiple perspectives into a transdisciplinary research platform.
Our interdisciplinary team is committed to pioneering research and education, shaped by the insights of patients and caregivers, to humanize health care and enhance the journey and outcomes of those impacted by cancer throughout their care trajectory.
Our objectives are to:
By advancing the science and practice of cancer care, we will ensure that all individuals affected by cancer receive the highest quality, state-of-the-art care that is personalized to their physical, psychosocial, and spiritual needs.
CORE faculty, in collaboration with researchers and educators at the Dana-Farber Cancer Institute, host multiple training workshops for junior investigators from around the world:
CORE is a unique, collaborative research team with members from oncology, nursing, palliative care, psychiatry, and psychology.
NEJM: Early palliative care for patients with metastatic non-small-cell lung cancer.
In this video, lead authors Jennifer Temel, MD and Vicki Jackson, MD, MPH discuss the findings of this landmark study.
A Decade of Discovery at the Mass General Cancer Center
In this video, meet three individuals, including Jennifer Temel, MD, who have a gift for developing the Everyday Amazing relationships that make the Mass General Cancer Center so special.
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago featured several CORE faculty presenting groundbreaking research.
ASCO 2024
Co-Principal Investigator Joseph Greer gave a comprehensive presentation on the 22-site REACH PC study, "Comparative Effectiveness Trial of Early Integrated Telehealth Versus In-Person Palliative Care for Patients with Advanced Lung Cancer," at the ASCO 2024 plenary session.
ASCO 2024
Members of the CORE team attended Joseph Greer’s plenary talk in front of more than 40,000 attendees. ( l-r: Chardria Trotter, MBA, MPH Simone Rinaldi, MSN, ANP-BC, ACHPN, Ryan Nipp, MD, Joseph Greer, PhD, Jennifer Temel, MD, Areej El-Jawahri, MD, and Vicki Jackson, MD, MPH)
ASCO 2024
Members of the CORE team gathered in downtown Chicago following the ASCO 2024 plenary sessions.
ASCO 2024
Dr. Areej El-Jawahri led an ASCO educational session titled “Integrating Palliative Care and Hematological Malignancies: Bridging the Gaps for Our Patients.”
ASCO 2024
Dr. Jennifer Temel & Chardria Trotter supported Dr. Deborah Forst on her ASCO poster presentation, “Coping in caregivers of patients with primary malignant brain tumors: A mediation analysis of a randomized controlled trial.” (l-r: Chardria Trotter, MBA, MPH, Deborah Forst, MD, Jennifer Temel, MD)
If you would like to contact the CORE program to inquire about volunteer or collaboration opportunities, please contact us here.
This helped lead to new knowledge and breakthrough therapies.
A world leader in cancer research & comprehensive cancer treatment, we are dedicated to educating the next generation of cancer specialists.
Findings suggest that this is an effective and more scalable means to deliver palliative care to improve patients’ quality of life.
Contact us to make an appointment or to learn more about our programs.